Threats of a federal government shutdown have gone from being an October surprise to a recurring theme. This time around, though, the stakes are higher. Federal funding ran out at midnight on Oct. 1, after Congress failed to pass even a stopgap budget while negotiations continued. Now the question is how long the deadlock will…
Sharpen your quills, brave souls. The spirits of health care bills past, present, and future are calling … and they demand haikus. Submissions are now open for KFF Health News’ seventh annual Halloween haiku competition. KFF Health News has been publishing reader-submitted health care haikus for years and is dying to read your frightful inspirations….
“An Arm and a Leg” senior producer Emily Pisacreta recently lost a job that provided her with health insurance. So now, for the first time, she will be signing up for Obamacare. Her search is off to a rocky start. Pisacreta gives listeners a sobering look at how the high price of health insurance plans…
September has seen a wide range of executive hires, exits, promotions and layoffs across the healthcare industry. For example, Medtronic, Amgen and Kaiser Permanente welcomed new executives. There were also layoffs at organizations including Novo Nordisk and Seattle Children’s. The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs appeared first on MedCity…
Newly launched Pfizer drugs will be priced at parity to prices in comparable developed nations, according to the most-favored nation pricing agreement. But industry observers note that big pharma companies are also raising some prices overseas as part of a strategy to protect U.S. revenue. The post Pfizer Reaches Deal on Most-Favored Nation Drug Pricing;…
EndPoints notes that the Most Favored Nation Executive Order has led some large pharmaceutical firms to make two changes: (i) start charging Europeans the same price as the US, and (ii) start selling more products direct to consumer (a.k.a. ‘pharm to table‘) AbbVie, Novartis and Boehringer Ingelheim each joined their peers in making price-related concessions…
With Millie’s new perimenopause and menopause offerings, patients receive treatments like hormone therapy, non-hormonal medications, vaginal treatments and lifestyle strategies for symptom relief. The post Millie Introduces Perimenopause and Menopause Program appeared first on MedCity News.
With Millie’s new perimenopause and menopause offerings, patients receive treatments like hormone therapy, non-hormonal medications, vaginal treatments and lifestyle strategies for symptom relief. The post Millie Introduces Perimenopause and Menopause Program appeared first on MedCity News.
In this episode, we’re joined by Priyanka Jain, CEO and co-founder of Evvy, a vaginal health company. Jain discusses how Evvy is trying to improve women’s health research and what she hopes to achieve as a founding member of the Milken Institute’s Women’s Health Network. The post MedCity FemFwd: How Evvy Is Advancing Women’s Health…
In this episode, we’re joined by Priyanka Jain, CEO and co-founder of Evvy, a vaginal health company. Jain discusses how Evvy is trying to improve women’s health research and what she hopes to achieve as a founding member of the Milken Institute’s Women’s Health Network. The post MedCity FemFwd: How Evvy Is Advancing Women’s Health…